These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25578527)

  • 21. The effect of carbapenem antibiotics on plasma concentrations of valproic acid.
    Mancl EE; Gidal BE
    Ann Pharmacother; 2009 Dec; 43(12):2082-7. PubMed ID: 19934386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seizures from valproate-carbapenem interaction.
    Taha FA; Hammond DN; Sheth RD
    Pediatr Neurol; 2013 Oct; 49(4):279-81. PubMed ID: 23932807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs.
    Suzuki E; Nakai D; Ikenaga H; Fusegawa K; Goda R; Kobayashi N; Kuga H; Izumi T
    Xenobiotica; 2016; 46(2):126-31. PubMed ID: 26075835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations.
    Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL
    Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures.
    Yu KT; Mills S; Thompson N; Cunanan C
    Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intentional use of carbapenem antibiotics for valproic acid toxicity: A case report.
    Khobrani MA; Dudley SW; Huckleberry YC; Kopp BJ; Biggs AD; French RNE; Shirazi FM; Erstad BL
    J Clin Pharm Ther; 2018 Oct; 43(5):723-725. PubMed ID: 29733112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Panipenem-betamipron and decreases in serum valproic acid concentration.
    Yamagata T; Momoi MY; Murai K; Ikematsu K; Suwa K; Sakamoto K; Fujimura A
    Ther Drug Monit; 1998 Aug; 20(4):396-400. PubMed ID: 9712464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China.
    Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Ther Drug Monit; 2016 Dec; 38(6):738-743. PubMed ID: 27855134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients.
    Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Xiao J; Chen XP
    J Clin Pharm Ther; 2017 Apr; 42(2):221-227. PubMed ID: 28145574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy.
    Cloyd JC; Kriel RL; Fischer JH; Sawchuk RJ; Eggerth RM
    Neurology; 1983 Feb; 33(2):185-91. PubMed ID: 6401848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.
    Poolos NP; Castagna CE; Williams S; Miller AB; Story TJ
    Epilepsy Behav; 2017 Apr; 69():59-68. PubMed ID: 28235655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment.
    Chiba K; Suganuma T; Ishizaki T; Iriki T; Shirai Y; Naitoh H; Hori M
    J Pediatr; 1985 Apr; 106(4):653-8. PubMed ID: 3920375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between valproic acid and carbapenems: decreased plasma concentration of valproic acid and liver injury.
    Li Z; Gao W; Liu G; Zhang Z
    Ann Palliat Med; 2021 May; 10(5):5417-5424. PubMed ID: 34107696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of drug interactions between carbapenems and valproate on serum valproate concentration: a systematic review and meta-analysis.
    Chai PY; Chang CT; Chen YH; Chen HY; Tam KW
    Expert Opin Drug Saf; 2021 Feb; 20(2):215-223. PubMed ID: 33322967
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of UGT2B7 genotypes on plasma concentration of valproic acid: a meta-analysis.
    Wang P; Lin XQ; Cai WK; Xu GL; Zhou MD; Yang M; He GH
    Eur J Clin Pharmacol; 2018 Apr; 74(4):433-442. PubMed ID: 29243113
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of steady-state valproate levels by other antiepileptic drugs.
    Sackellares JC; Sato S; Dreifuss FE; Penry JK
    Epilepsia; 1981 Aug; 22(4):437-41. PubMed ID: 6790273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacokinetic interaction between valproic acid and meropenem].
    Sala Piñol F; Padullés Zamora N; Hidalgo Albert E; Clemente Bautista S; Cabañas Poy MJ; Oliveras Arenas M; Balcells Ramírez J
    An Pediatr (Barc); 2006 Jan; 64(1):93-5. PubMed ID: 16539924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.